Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

CG Oncology (CGON) Accumulated Depreciation & Amortization (2024 - 2025)

CG Oncology filings provide 2 years of Accumulated Depreciation & Amortization readings, the most recent being $1.5 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 1594.25% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 1594.25% increase, with the full-year FY2025 number at $1.5 million, up 1594.25% from a year prior.
  • Accumulated Depreciation & Amortization hit $1.5 million in Q4 2025 for CG Oncology, up from $623000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.5 million in Q4 2025 to a low of $87000.0 in Q4 2024.